Leen Limbourg

Leen LIMBOURG holds a prominent position in various leadership roles across multiple organizations, including serving as a Member of the Board of Directors at Radiomics.bio, PDC*line Pharma, ABSCINT, and THERAtRAME. As of January 2024, LIMBOURG also holds the title of Chairwoman of the Supervisory Board at Delta Diagnostics. Additionally, LIMBOURG is an Executive Committee Member at White Fund SA, a VC in Investment Management at Noshaq, and Chairwoman of the Board at Op2Lysis. LIMBOURG actively participates in academia as a Member of the IOF Council at KU Leuven and has pursued extensive education, including degrees in Medicine, Health Economics, an International MBA, and specialized training in leadership and board effectiveness from renowned institutions.